Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27605912 | 0.79 | — | — | |
| SCHEMBL27623376 | 0.79 | KEAP1 (0.31) | — | |
| Hydrochloric Acid SCHEMBL27605906 | 0.78 | — | — | |
| SCHEMBL28262576 | 0.77 | — | — | |
| SCHEMBL3874816 | 0.77 | — | — | |
| SCHEMBL3861981 | 0.77 | — | — | |
| SCHEMBL3874819 | 0.77 | — | — | |
| SCHEMBL2241969 | 0.77 | — | — | |
| Hydrochloric Acid SCHEMBL5498424 | 0.76 | TSHR (0.37) | TSHRHSD17B10 | |
| SCHEMBL6590939 | 0.74 | ALOX15 (0.41) | ALDH1A1TSHRHSD17B10GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140249076-A1 | AMYLIN-CALCITONIN CHIMERIC PEPTIDES CONJUGATED TO DURATION ENHANCING MOIETIES | ASTRAZENECA PHARMACEUTICALS LP | 2014-09-04 | — | — | US | disclosed |
| WO-2013059336-A1 | AMYLIN-CALCITONIN CHIMERIC PEPTIDES CONJUGATED TO DURATION ENCHANCING MOIETIES | AMYLIN PHARMACEUTICALS, LLC (US) | 2013-04-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140249076-A1 | AMYLIN-CALCITONIN CHIMERIC PEPTIDES CONJUGATED TO DURATION ENHANCING MOIETIES | IAPP, GIPR, VIP | ALDH1A1 3723/4885TSHR 1233/4885HSD17B10 2504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.